| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 04/18/2002 | WO2002031109A2 Intracellular delivery of biological effectors by novel transporter peptide sequences |
| 04/18/2002 | WO2002030986A2 HUMANIZED ANTI-LT-β-R ANTIBODIES |
| 04/18/2002 | WO2002030958A2 Casein peptide fragments with growth-influencing activity on cell cultures |
| 04/18/2002 | WO2002030268A2 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer |
| 04/18/2002 | WO2002008272A3 High affinity soluble interleukin-18 receptor |
| 04/18/2002 | WO2002008252A3 Novel protein containing ring finger domaine r1p4 |
| 04/18/2002 | WO2001083744A3 Natrium-calcium exchanger protein |
| 04/18/2002 | WO2001070985A3 Bi-functional cancer treatment agents |
| 04/18/2002 | WO2001064876A3 Human schizophrenia gene |
| 04/18/2002 | WO2001061007A9 Fibroblast growth factor-23 molecules and uses thereof |
| 04/18/2002 | WO2001058916A3 Antibodies to ccr5 |
| 04/18/2002 | WO2001051520A3 Nogo receptor-mediated blockade of axonal growth |
| 04/18/2002 | WO2001032684A3 Method for linking molecular substances based on the affinity of the proline-rich amino acid sequences and protein domains of type ww |
| 04/18/2002 | WO2000067793A9 Death domain containing receptor 4 |
| 04/18/2002 | US20020045577 Human schizophrenia gene |
| 04/18/2002 | US20020045568 Use of mp52 0r mp121 for treating and preventing diseases of the nervous system |
| 04/18/2002 | US20020045264 Expression vectors for use in gene therapy |
| 04/18/2002 | US20020045213 IL-17 receptor like molecules and uses thereof |
| 04/18/2002 | US20020045208 Nucleotide sequences which code polypeptides for use in treatment of autoimmune diseases, allergies and tumors |
| 04/18/2002 | US20020045201 Sreening drugs for use in treatment of nervous system disorders; obtain protein sample, mix with modulator, monitor complex formation, compare to control, adjustment in concentration of preferential complex indicates modulator |
| 04/18/2002 | US20020045193 Polypeptide for use in purifying and separation of target peptides |
| 04/18/2002 | US20020044950 Recombinant toxin fragments |
| 04/18/2002 | US20020044937 Where the protein binds to T-cell cell surface protein, and that complex with nucleic acids, for transporting nucleic acids into human or animal cells which express the T-cell surface protein; antisense therapy, HIV therapy |
| 04/18/2002 | CA2425809A1 Humanized anti-lt-.beta.-r antibodies |
| 04/18/2002 | CA2425610A1 Intracellular delivery of biological effectors by novel transporter peptide sequences |
| 04/18/2002 | CA2425569A1 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer |
| 04/18/2002 | CA2424433A1 Bvh-a2 and bvh-a3 antigens of group b streptococcus |
| 04/17/2002 | EP1197550A2 Methods and compositions for diagnosing and treating disorders involving angiogenesis |
| 04/17/2002 | EP1196772A2 Induction of a th1-like response in vitro |
| 04/17/2002 | EP1196585A1 Insecticidal proteins from paecilomyces and synergistic combinations thereof |
| 04/17/2002 | EP1196577A2 Cell cycle and proliferation proteins |
| 04/17/2002 | EP1196565A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 04/17/2002 | EP1196442A1 Vgf polypeptides and methods of treating vgf-related disorders |
| 04/17/2002 | EP1196191A1 Death domain containing receptor 5 |
| 04/17/2002 | EP1196026A1 Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism |
| 04/17/2002 | EP0935609B1 Crystallizable compositions comprising a hepatitis c virus ns3 protease domain/ns4a complex and crystals thereby obtained |
| 04/17/2002 | CN1345374A HER-2/neu fusion proteins |
| 04/17/2002 | CN1345336A Antibody and chemokine constructs and their use for treating autoimmune diseases |
| 04/17/2002 | CN1344744A Human testicular development specific protein-27 gene encoding protein |
| 04/17/2002 | CN1344743A Human testicular development specific protein-26 gene encoding protein |
| 04/17/2002 | CN1344742A Human testicualr development specific protein-24 gene encoding protein |
| 04/17/2002 | CN1344741A Human testicular development specific protein-21 gene encoding protein |
| 04/17/2002 | CN1344740A Human testicular development specific protein-20 gene encoding protein |
| 04/17/2002 | CN1344739A Human testicular development specific protein-20B gene encoding protein |
| 04/17/2002 | CN1344738A Human testicular development specific protein-18 gene encoding protein |
| 04/17/2002 | CN1344737A Human testicular development specific protein-5 gene encoding protein |
| 04/17/2002 | CN1344736A 9-0-acetyl esterase gene encoding protein |
| 04/17/2002 | CN1344735A Human testicular development specific protein-19 gene encoding protein |
| 04/17/2002 | CN1082821C Antibody cojugates |
| 04/16/2002 | US6372957 Transgenic mouse comprising a MEF2 binding site operatively linked to an indicator gene and methods of use |
| 04/16/2002 | US6372490 Nucleic acid encoding the MDM interacting protein |
| 04/16/2002 | US6372471 Cloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 04/16/2002 | US6372207 IFNAR2/IFN complex |
| 04/11/2002 | WO2002029059A2 Nogo receptor homologs |
| 04/11/2002 | WO2002028902A2 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 04/11/2002 | WO2002028888A2 Mimotope of neisseria meningitides lipooligosaccharide and vaccines containing the same |
| 04/11/2002 | WO2002028414A1 Compositions and methods for wt1 specific immunotherapy |
| 04/11/2002 | WO2001092308A3 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 04/11/2002 | WO2001085935A3 Endothelial differentiation gene 6-like g protein coupled receptor |
| 04/11/2002 | WO2001083768A3 Serine-threonine kinase |
| 04/11/2002 | WO2001077148A3 Human lipid binding protein 1 |
| 04/11/2002 | WO2001065262A3 Reagents and methods useful for detecting diseases of the breast |
| 04/11/2002 | WO2000036103A9 Cytokine receptor chain |
| 04/11/2002 | US20020042502 Preparation of capped mRNA |
| 04/11/2002 | US20020042368 Integrin antagonists |
| 04/11/2002 | DE10048417A1 Verbindungen mit verzweigtem Linker Compounds with branched linker |
| 04/11/2002 | DE10043481A1 Humaner Antikörper gegen Endoglin (CD105) und seine Verwendung Human antibodies against endoglin (CD105) and its use |
| 04/11/2002 | CA2425072A1 Wt1 fusion polypeptides and methods for wt1 immunotherapy |
| 04/11/2002 | CA2424834A1 Nogo receptor homologs |
| 04/11/2002 | CA2424543A1 Component for vaccine |
| 04/11/2002 | CA2423462A1 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 04/10/2002 | EP1195161A2 Anti-IgE vaccines |
| 04/10/2002 | EP1194569A2 Seripancrin |
| 04/10/2002 | EP1194561A2 Donor strand complemented pilin and adhesin broad-based vaccines |
| 04/10/2002 | EP1194551A1 G-protein coupled receptor and dna sequences thereof |
| 04/10/2002 | EP1194528A1 Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
| 04/10/2002 | EP1194451A1 Fusion peptides comprising a peptide ligand domain and a multimerization domain |
| 04/10/2002 | EP1194167A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 04/10/2002 | EP1194164A1 Prion protein peptides and uses thereof |
| 04/10/2002 | EP1178116A9 Sid nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof |
| 04/10/2002 | CN1344287A Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 04/10/2002 | CN1344166A Use of enterobacterium protein ompA associated with antigen for generating antiviral, antiparasitic or antitumoral cytotoxic response |
| 04/09/2002 | US6369211 MAGE-3 peptides presented by HLA class II molecules |
| 04/09/2002 | US6369027 Osteoprotegerin |
| 04/09/2002 | US6368853 A nucleic acid encoding a polypeptide ligand; tyrosine kinase containing immunoglobulin and epidermal growth factor homolog domains; therapy and diagnosis for angiogenesis in wound healing, inflammation or tumors |
| 04/09/2002 | CA2083271C Fibrin binding domain polypeptides and uses and methods of producing same |
| 04/04/2002 | WO2002027327A2 Rapid profiling of the interactions between a chemical entity and proteins in a given proteome |
| 04/04/2002 | WO2002027315A2 Compounds with a branched linker |
| 04/04/2002 | WO2002026988A2 Human drug metabolizing enzymes |
| 04/04/2002 | WO2002026951A2 Oxidoreductases |
| 04/04/2002 | WO2002026833A1 Compositions and methods for the endocytic presentation of immunosuppressive factors |
| 04/04/2002 | WO2002026822A2 Pumpcn compositions and uses thereof |
| 04/04/2002 | WO2002026779A2 A fibrin/fibrinogen-binding conjugate |
| 04/04/2002 | WO2001085980A3 Enzymatic assays for screening anti-cancer agents |
| 04/04/2002 | WO2001085921A3 Human serine-threonine kinase-4 |
| 04/04/2002 | WO2001073034A3 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 04/04/2002 | WO2001073033A3 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 04/04/2002 | WO2001072846A3 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |
| 04/04/2002 | WO2001068695A3 Factor-h related protein 5 (fhr-5) and antibodies thereto |
| 04/04/2002 | WO2001055178A9 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |